QIAGEN N.V. logo
QIAGEN N.V. QGEN

Annual report 2025
added 04-04-2026

report update icon

QIAGEN N.V. Net Income 2011-2026 | QGEN

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income QIAGEN N.V.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
425 M 83.6 M 341 M 423 M 513 M 359 M -41.5 M 190 M 40.4 M 80.4 M 127 M 117 M 69.1 M 130 M 96 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
513 M -41.5 M 197 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Diagnostics research industry

Issuer Net Income Price % 24h Market Cap Country
BioNano Genomics BioNano Genomics
BNGO
-26.4 M $ 1.14 0.44 % $ 6.21 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
-797 M $ 16.07 1.39 % $ 173 M chinaChina
Centogene N.V. Centogene N.V.
CNTG
-46.9 M - -6.23 % $ 30.6 M germanyGermany
Agilent Technologies Agilent Technologies
A
1.21 B $ 115.09 0.03 % $ 35 B usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
24.6 M $ 2.25 -2.17 % $ 9.95 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
-12.8 M - -6.19 % $ 10.5 M usaUSA
Biocept Biocept
BIOC
-32.1 M - -13.05 % $ 7.29 M usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
-23.3 M - 0.22 % $ 16.8 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
-25.1 M - - $ 9.42 M israelIsrael
DermTech DermTech
DMTK
-101 M - -11.32 % $ 2.94 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
-21.4 M $ 16.32 1.65 % $ 870 M usaUSA
Medpace Holdings Medpace Holdings
MEDP
451 M $ 498.22 0.95 % $ 14.4 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
-1.81 M - - $ 562 M britainBritain
Akumin Akumin
AKU
-157 M - -17.87 % $ 25.9 M canadaCanada
Myriad Genetics Myriad Genetics
MYGN
-366 M $ 4.45 2.3 % $ 412 M usaUSA
NeoGenomics NeoGenomics
NEO
-108 M $ 7.87 2.34 % $ 1.01 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
-26.1 M - -8.98 % $ 14.8 K usaUSA
Co-Diagnostics Co-Diagnostics
CODX
-46.9 M $ 1.4 2.19 % $ 1.86 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
-208 M - - $ 19.8 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-14.6 M - -61.36 % $ 2.46 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
18.2 M $ 23.05 -0.35 % $ 640 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
501 M - - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
-53 M - 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
-7.13 M - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
-503 M - 0.12 % $ 80.1 M chinaChina
Senseonics Holdings Senseonics Holdings
SENS
-69.1 M $ 6.62 -0.9 % $ 276 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
-144 M $ 176.51 0.49 % $ 8.75 B usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
197 M - - $ 10.7 B usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
20.9 M $ 52.58 -0.1 % $ 2.67 B usaUSA
Danaher Corporation Danaher Corporation
DHR
3.61 B $ 190.99 0.73 % $ 136 B usaUSA
Neuronetics Neuronetics
STIM
-39 M $ 1.37 1.11 % $ 90.4 M usaUSA
Heska Corporation Heska Corporation
HSKA
-19.9 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
-21.6 M - -20.0 % $ 1.06 M usaUSA
Illumina Illumina
ILMN
-1.22 B $ 122.69 1.46 % $ 19.5 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
-42.7 M $ 14.96 3.67 % $ 452 M usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
6.7 B $ 500.25 0.83 % $ 189 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
929 K $ 0.69 -3.28 % $ 61.9 M irlandaIrlanda
Guardant Health Guardant Health
GH
-416 M $ 79.27 0.85 % $ 9.94 B usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
-77.7 M $ 48.44 1.11 % $ 2.9 B usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
-10.9 M $ 2.73 1.49 % $ 88.6 K usaUSA
Biomerica Biomerica
BMRA
-4.97 M $ 2.1 -2.1 % $ 4.82 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
-99.8 M - - $ 21.2 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
3.32 B $ 28.26 -0.18 % $ 20 B niderlandNiderland
ICON Public Limited Company ICON Public Limited Company
ICLR
791 M $ 107.45 0.59 % $ 8.86 B irlandaIrlanda
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
876 M $ 261.12 0.07 % $ 21.7 B usaUSA
Natera Natera
NTRA
-548 M $ 197.55 2.34 % $ 19.4 B usaUSA
Celcuity Celcuity
CELC
-177 M $ 118.08 0.8 % $ 5.52 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
234 M $ 80.41 -0.23 % $ 5.43 B usaUSA
Waters Corporation Waters Corporation
WAT
643 M $ 318.26 -0.54 % $ 19 B usaUSA